title: The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays.
authors.affiliation: Harvard Medical School and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
authors.forename: Y A
authors.initials: YA
authors.lastname: Kim
authors.affiliation: Davis Health System, University of California, Sacramento, CA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Gosselin
authors.affiliation: Harvard Medical School and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. evancott@mgh.harvard.edu.
authors.forename: E M
authors.initials: EM
authors.lastname: Van Cott
mesh_terms: D000925:Anticoagulants / Q000494:pharmacology*; D000991:Antithrombins / Q000494:pharmacology; D001773:Blood Cells / Q000187:drug effects*; D001777:Blood Coagulation / Q000187:drug effects*; D002478:Cells, Cultured; D000069604:Dabigatran / Q000494:pharmacology*; D005189:False Positive Reactions; D005340:Fibrinogen / Q000494:pharmacology; D006801:Humans; D019934:International Normalized Ratio; D016682:Lupus Coagulation Inhibitor / Q000494:pharmacology; D011486:Protein C / Q000378:metabolism; D017293:Protein S / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D013918:Thrombin Time
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D016682:Lupus Coagulation Inhibitor; D011486:Protein C; D017293:Protein S; D005340:Fibrinogen; D000069604:Dabigatran